NRG Oncology NRG-BN006: A phase II/III randomized, open-label study of Toca 511 and Toca FC with standard of care compared to standard of care in patients with newly diagnosed glioblastoma

fluorouracil - Generic mfg.

BN 006 - Botanix Pharmaceuticals

vocimagene amiretrorepvec (Toca 511) - Tocagen

https://www.eventscribe.com/2019/sno/agenda.asp?pfp=FullSchedule

Manmeet Ahluwalia;Stephanie Pugh;Benjamin Ellingson;Rupesh Kotecha;Timothy Cloughesy;Michael Vogelbaum;Kenneth Aldape;Yunfeng Cui;Terri Armstrong;Minesh Mehta

Oct 29, 2019